(Q47246192)

12 January 2018

title

Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma (English)

1 reference

12 January 2018

0 references

1 reference

10

1 reference

12 January 2018

Jean-Michel Foidart

6

object named as

Jean-Michel Foidart

1 reference

12 January 2018

Jonathan Hacha

1

1 reference

12 January 2018

Kate Tomlinson

2

1 reference

12 January 2018

Ludovic Maertens

3

1 reference

12 January 2018

Geneviève Paulissen

4

1 reference

12 January 2018

Natacha Rocks

5

1 reference

12 January 2018

Agnès Noel

7

1 reference

12 January 2018

Roger Palframan

8

1 reference

12 January 2018

Maud Gueders

9

1 reference

12 January 2018

publication date

16 August 2012

1 reference

12 January 2018

American Journal of Respiratory Cell and Molecular Biology

published in

1 reference

12 January 2018

volume

47

1 reference

12 January 2018

issue

5

1 reference

12 January 2018

page(s)

709-717

1 reference

12 January 2018

Asthma and allergic inflammation

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

The cytokine network in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Cytokine and anti-cytokine therapy in asthma: ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Alternatively activated macrophages and airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Functions of T cells in asthma: more than just T(H)2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Interleukin-13 in asthma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

IL-13 as a therapeutic target for respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Cytokine antagonists for the treatment of asthma: progress to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Cytokine inhibition in severe asthma: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Lebrikizumab treatment in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Matrix metalloproteinase-19 deficiency promotes tenascin-C accumulation and allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Effects of anticytokine therapy in a mouse model of chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Preclinical Safety and Pharmacology of an Anti-Human Interleukin-13 Monoclonal Antibody in Normal Macaques and in Macaques with Allergic Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

Receptor internalization is required for eotaxin-induced responses in human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0031OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2012-0031OC

1 reference

12 January 2018

1 reference

12 January 2018